Neurology & Neurosurgery
Neurology practices, neurosurgery groups, and sleep medicine programs treating brain, spine, and nervous system conditions.
- 4
- Verticals
Overview
Neurology & Neurosurgery covers neurology practices, neurosurgery groups, and sleep-medicine programs treating brain, spine, and nervous-system conditions. It spans cognitive neurology, interventional and surgical neuro care, and sleep diagnostics.
Demand is supported by aging, neurodegenerative disease, and chronic neurological conditions, with infusion (for MS and migraine biologics) and diagnostics as ancillary opportunities. It has been a less-consolidated specialty than procedure-rich fields, with emerging MSO interest.
Market snapshot
Within Offices of Physicians (NAICS 621111); the Census Bureau does not split physician offices by specialty, so neurology is not separately sized.
Business model & economics
Revenue model
Office, diagnostic, and infusion reimbursement
Key economics
- Recurring revenue
- Moderate
- EBITDA margin
- 15–25%
- Capex intensity
- Low
chronic neurological care recurs
Characteristics
- Aging and neurodegenerative disease drive demand.
- Infusion and diagnostics as ancillary opportunities.
- Less consolidated than procedure-rich specialties.
M&A deal context
Who’s acquiring
- Emerging neurology MSO platforms
- Multispecialty groups
- Infusion-aligned acquirers
What’s driving deals
- Emerging neurology consolidation.
- Aging and chronic-disease demand.
- Biologic-infusion ancillary economics.
Verticals in this segment
Find Neurology & Neurosurgery acquisition targets
Search Acquisera’s index for companies classified under Neurology & Neurosurgery (4.10.14) and build a targeted deal pipeline.
Search companies